PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. (Q43040958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Francisco Sánchez-Madrid

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Pilar Sandoval

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

Guadalupe T González-Mateo

5 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Maria-Luisa Pérez Lozano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Marta Ruiz-Ortega

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Marta Ruiz-Ortega

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Manuel López Cabrera

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Jesús Loureiro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Alejandra Maldonado-Rodríguez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

José A Sánchez-Tomero

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Lorea Mendoza

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Beatriz Santamaría

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Rafael Selgas

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Abelardo Aguilera

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Alberto Ortiz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

7 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1517-1532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20531289%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.111

5 February 2020

exact match

0 references

cites work

Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Peritoneal dialysis: diabetes of the peritoneal cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Transforming growth factor-alpha prevents detachment-induced inhibition of c-Src kinase activity, Bcl-XL down-regulation, and apoptosis of intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Integration of metabolism and inflammation by lipid-activated nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Emerging roles of PPARs in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Ciglitazone induces apoptosis via activation of p38 MAPK and AIF nuclear translocation mediated by reactive oxygen species and Ca(2+) in opossum kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Leptin augments myofibroblastic conversion and fibrogenic activity of human peritoneal mesothelial cells: a functional implication for peritoneal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Peroxisome proliferator-activated receptor gamma agonists in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

The peritoneal membrane in chronic peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

Myofibroblastic conversion of mesothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

Peroxisome Proliferator-Activated Receptor-γ Agonists Diminish Peritoneal Functional and Morphological Changes Induced by Bioincompatible Peritoneal Dialysis Solution

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

Adipokine signaling in the peritoneal dialysis patient.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

Leptin induces TGF-beta synthesis through functional leptin receptor expressed by human peritoneal mesothelial cell

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021

How safe is the use of thiazolidinediones in clinical practice?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.111

7 January 2021